Ashutosh S Parihar (Ashutosh Parihar)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Pulmonary Artery

Lipopolysaccharide Induced

Cell Proliferation

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Evaristus C Mbanefo, Allison Seifert, Manoj Kumar Yadav, Cheng-Rong Yu, Vijayaraj Nagarajan, Ashutosh S Parihar, Sunanda Singh, Charles E Egwuagu
A Camelid-Derived STAT-Specific Nanobody Inhibits Neuroinflammation and Ameliorates Experimental Autoimmune Encephalomyelitis (EAE). Cells 13 (12) (2024)
Evaristus C Mbanefo, Allison Seifert, Manoj Kumar Yadav, Cheng-Rong Yu, Vijayaraj Nagarajan, Ashutosh S Parihar, Sunanda Singh, Charles E Egwuagu
A Camelid-Derived STAT-Specific Nanobody Inhibits Neuroinflammation and Ameliorates Experimental Autoimmune Encephalomyelitis (EAE). Cells 13 (12) (2024)
Evaristus C Mbanefo, Allison Seifert, Manoj Kumar Yadav, Cheng-Rong Yu, Vijayaraj Nagarajan, Ashutosh S Parihar, Sunanda Singh, Charles E Egwuagu
A Camelid-Derived STAT-Specific Nanobody Inhibits Neuroinflammation and Ameliorates Experimental Autoimmune Encephalomyelitis (EAE). Cells 13 (12) (2024)
Sunanda Singh, Hector J Gomez, Shreya Thakkar, Samara P Singh, Ashutosh S Parihar
Overcoming Acquired Drug Resistance to Cancer Therapies through Targeted STAT3 Inhibition. International journal of molecular sciences 24 (5) (2023)
Sunanda Singh, Hector J Gomez, Shreya Thakkar, Samara P Singh, Ashutosh S Parihar
Overcoming Acquired Drug Resistance to Cancer Therapies through Targeted STAT3 Inhibition. International journal of molecular sciences 24 (5) (2023)
Sunanda Singh, Hector J Gomez, Shreya Thakkar, Samara P Singh, Ashutosh S Parihar
Overcoming Acquired Drug Resistance to Cancer Therapies through Targeted STAT3 Inhibition. International journal of molecular sciences 24 (5) (2023)